S

ARS Pharmaceuticals
D

SPRY

11.240
USD
-0.53
(-4.50%)
مغلق
حجم التداول
32,659
الربح لكل سهم
-0
العائد الربحي
-
P/E
-22
حجم السوق
1,092,364,739
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: ARS Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.